LINDON, Utah, June 8, 2006 (PRIMEZONE) -- EAU Technologies, Inc. (EAU) (OTCBB:EAQU), the leading provider of electrolyzed oxidative water, that promotes "Green Chemistry" to numerous industries including food processing, agriculture and consumer products, today announced the test results of its Electrolyzed Oxidative water (marketed as Empowered Water(tm)) in a major poultry processing plant. EAU's non-toxic antimicrobial water technology proved more than twice as effective in reducing Salmonella and aerobic plate count numbers. The same solution was 70% more effective in reducing total coliform and E. coli counts in the plant compared to the currently used chemical solutions.
"We ran a five week study in a major facility with two parallel lines running 120 birds per minute in each line. One line used the facility's USDA approved process and the other used EAU's efficacious and environmentally friendly Empowered Water(tm) technology. While both lines running in the facility were well below the USDA guidelines for efficacy and safety, the line that employed Empowered Water(tm) technology showed significantly greater reductions in Salmonella, E. coli and coliform," said Jay Potter, EAU's Interim CEO. "Salmonella is tested on a presence/absence basis. Our technology proved to be more than twice as effective in combating Salmonella compared to the technology currently being used in this particular facility. In a laboratory environment with all things controlled, it is easier to show efficacy with new technologies. This was a practical application in a major high volume plant exposing the technology to the numerous variables associated with daily processing operations. With this high volume validation, we now firmly believe that our non-toxic Empowered Water(tm) process will become the standard in not only the poultry industry but all food processing where pathogens are being combated."
According to the CDC, there are an estimated 1.4 million cases of Salmonella infections every year in the US alone. The Economic Research Service (ERS) estimates the cost associated with treating Salmonellosis in humans is $2.4 billion annually. While not all cases of Salmonellosis in humans can be associated with poultry, Salmonella is commonly found on chickens and therefore occurrence levels are strictly monitored by the USDA within the poultry industry. Multiresistant strains of Salmonella are now encountered more frequently, limiting the health care system's ability to effectively treat human infections.
"What is great about our technology is that we get a physical kill on bacteria as opposed to the chemical kill on which most of our competition rely," stated Potter. "A physical kill makes it virtually impossible for pathogens to create resistance to our technology."
About EAU:
EAU Technologies, Inc. (EAU) is a supplier of Electrolyzed Oxidative Water Technology (EOW Technology marketed as Empowered Water(tm)) and other complementary technologies with applications in diverse industries. EAU's water-based and non-toxic (at application concentration, the solutions are non-toxic to humans and live animals) EOW Technology may replace many of the traditional methods now used to clean, disinfect, protect and nourish in large industries such as agriculture and food processing. EAU has solutions for existing bacteria, virus and mold proliferation threats. EAU continues to add innovative and efficacious products that offer a systemic approach to pathogen elimination in food processing plants and related industries by treating not only surface contamination without toxicity but also the plant soils and animal foods, thereby producing safer foods and protecting the environment through "Green Chemistry."
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995
Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as ``may,'' ``will,'' ``should,'' ``could,'' ``expects,'' ``plans,'' ``intends,'' ``anticipates,'' ``believes,'' ``estimates,'' ``predicts,'' ``forecasts,'' ``potential,'' or ``continue,'' or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The company has no obligation to update these forward-looking statements.